Medy-Tox Inc. (086900) Stock Price & News

Why is 086900 down 2.37%?

Dive Deeper

086900:KOSDAQ

Medy-Tox Inc.

₩65,900.00

-2.37%

(-1,600.00) 1D

Oct 8, 3:30:30 PM GMT+9 · KRW

All symbols

	Symbol	Price	Change	% Change

Generating top insights for 086900...

Open

₩67,700

High

₩67,700

Low

₩65,800

Mkt. cap

480.97B

Avg. vol.

25.70K

Volume

17.09K

P/E ratio

31.72

52-wk high

₩141,100

52-wk low

₩65,600

EPS

₩2,077

Shares outstanding

7.30M

No. of employees

703

Open

₩67,700

High

₩67,700

Low

₩65,800

Mkt. cap

480.97B

Avg. vol.

25.70K

Volume

17.09K

P/E ratio

31.72

52-wk high

₩141,100

52-wk low

₩65,600

EPS

₩2,077

Shares outstanding

7.30M

No. of employees

703

Related stocks

Komipharm International Co Ltd

₩11,360.00

+3.27%

214450

PharmaResearch Co Ltd

News stories

From web sources and news partners

富途牛牛

33 minutes ago

As the yield on the 10-year U.S. Treasury note approaches 5.4%, the AI hype fails to mask concerns about the S&P 500's "hollow strength."

Tekedia

5 hours ago

Dow Futures Fall Nearly 500 Points as Oil Surges Over 5% and Treasury Yields Hit 24-Year Highs

ChartMill

9 hours ago

Friday's session: top gainers and losers in the dow jones index

The Washington Post

5 hours ago

How major US stock indexes fared Friday 10/9/2026

About Medy-Tox Inc.

CEOJung Hyunho

Employees703

FoundedMay 2, 2000

HeadquartersGangnam District, Seoul, South Korea

SectorBiotechnology

Websitemedytox.com

All values in KRW	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	61.02B	60.67B	60.69B	68.70B
Cost of goods sold	24.60B	24.93B	18.92B	27.63B
Cost of revenue	24.60B	24.93B	18.92B	27.63B
Research and development expenses	-	29.19B	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	27.52B	2.31B	34.39B	36.31B
Operating expense	27.52B	39.75B	34.39B	36.31B
Total operating expenses	52.12B	64.68B	53.32B	63.94B
Operating income	8.90B	-4.01B	7.37B	4.76B
Other non operating income	-519.03M	-1.19B	1.51B	807.29M
EBT including unusual items	7.78B	-13.98B	9.70B	4.26B
EBT excluding unusual items	7.78B	-10.68B	9.70B	4.26B
Income tax expense	581.80M	-10.93B	1.82B	1.13B
Effective tax rate	7.48%	78.14%	18.78%	26.57%
Other operating expenses	-	1.41B	-	-
Net income	7.43B	-3.02B	7.80B	3.11B
Net profit margin	12.18%	-4.97%	12.85%	4.52%
Earnings per share	-	-493.00	1.19K	479.00
Interest and investment income	-	1.40B	-	-
Interest expense	-	-649.39M	-	-
Net interest expenses	-	745.76M	-	-
Depreciation and amortization charges	-	1.57B	-	-
EBITDA	13.89B	1.00B	12.39B	9.78B
Gain or loss from assets sale	-	4.31B	-	-

Finance

Ask anything